Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-053880

Director sold 5,000 shares at $21.97 ($109,850)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lingnau Lutz Director 2017-09-22 Sale −5,000 $21.97 $109,850 27,450 D: show line 1 in the form
Open-market sales · 5,000 sh · avg $21.97 · $109,850
Loading xslF345X03/doc4.xml…